This story has been updated from a previous version.

NEW YORK, Oct 10 - Biopharmaceutical company Cytogen announced Tuesday that it had reached a deal with Acqua Wellington North American Equities Fund for an equity financing facility of up to $70 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.